| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |